Publication:
Therapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or Illusion?

Simple item page
dc.contributor.authorUner, Melike
dc.contributor.authorDamgali, Sukran
dc.contributor.authorOzdemir, Samet
dc.contributor.authorCelik, BURAK
dc.contributor.institutionauthorÇELİK, BURAK
dc.date.accessioned2019-10-05T13:31:44Z
dc.date.available2019-10-05T13:31:44Z
dc.date.issued2017-01-01
dc.description.abstractBackground: Solid lipid nanoparticles (SLN) are colloidal drug carrier systems that contribute several properties required from a sophisticated drug delivery system for increasing drug bioavailability and providing effective therapy. Many advantages of SLN have been reported over traditional dosage forms and their colloidal counterparts since the early 1990s. They were optimized for oral drug delivery for the first time. The first SLN formulations were produced by reducing particle size of solid lipid microparticles by spray congealing technique in the late 1980s. Then, studies have been continued investigating for their different administration routes else including parenteral, transdermal, ocular, nasal, respiratory etc.
dc.identifier10.3978/j.issn.2072-1439.2014.06.17
dc.identifier.citationUner M., Damgali S., Ozdemir S., Celik B., -Therapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or Illusion?-, CURRENT PHARMACEUTICAL DESIGN, cilt.23, ss.6573-6591, 2017
dc.identifier.pubmed29173153
dc.identifier.urihttps://hdl.handle.net/20.500.12645/2301
dc.language.isoen
dc.titleTherapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or Illusion?
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameJournal of thoracic disease
local.avesis.id37e6af77-dde3-4d33-9dce-7e0ffec0dfec
local.avesis.response2171
relation.isAuthorOfPublicationfb8ce36b-f920-4f90-a8b5-ea24535e608d
relation.isAuthorOfPublication.latestForDiscoveryfb8ce36b-f920-4f90-a8b5-ea24535e608d
Files
Collections
Yayınlar - Eserler
Eczacılık Fakültesi